Final report on the safety assessment of aloe andongensis extract, aloe andongensis leaf juice, aloe arborescens leaf extract, aloe arborescens leaf juice, aloe arborescens leaf protoplasts, aloe barbadensis flower extract, aloe barbadensis leaf, aloe barbadensis leaf extract, aloe barbadensis leaf juice, aloe barbadensis leaf polysaccharides, aloe barbadensis leaf water, ferox leaf extract,...

International Journal of Toxicology

Volumn 26, Issue SUPPL. 2, 2007, Pages 1-50

  Andersen, F Alan ^a  

^a Cosmetic Ingredient Review ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACEMANNAN; ACETYLSALICYLIC ACID; ALCOHOL; ALOE ANDONGENSIS EXTRACT; ALOE ARBORESCENS EXTRACT; ALOE BARBADENSIS EXTRACT; ALOE EMODIN; ALOE FEROX LEAF EXTRACT; ALOE FEROX LEAF JUICE EXTRACT; ALOE VERA EXTRACT; ALOIN; ANTHRAQUINONE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BENZO[A]PYRENE; BIS(2 OXOPROPYL)NITROSAMINE; EMODIN; FUNGICIDE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; INDOMETACIN; LAXATIVE; METHANOL; PESTICIDE; PLANT EXTRACT; POLYCHLORINATED BIPHENYL; POLYSACCHARIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE TOXICITY; ADVERSE OUTCOME; ALOE; ALOE VERA; ALOPECIA; ANALYTIC METHOD; ANTIHYPERTENSIVE ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ASEPTIC MENINGITIS; ASTHMA; BACTERIAL CELL; BLOOD; BURN; CANCER; CANCER INHIBITION; CARCINOGENICITY; CHRONIC PYELONEPHRITIS; CHRONIC TOXICITY; CLINICAL ASSESSMENT; COLD INJURY; CONTACT URTICARIA; CYTOTOXICITY; DEGENERATION; DEPRESSION; DERMATITIS; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM INFLAMMATION; DIZZINESS; DRUG INDUCED DISEASE; ECZEMA; ENZYME ACTIVITY; ERYTHEMA; FATIGUE; FECES; FEEDING; FLOWER; FUNGICIDAL ACTIVITY; GASTROINTESTINAL IRRITATION; GASTROINTESTINAL SYMPTOM; GEL; GENITAL HERPES; GENOTOXICITY; HEADACHE; HEART DISEASE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; IMMUNOLOGY; IN VITRO STUDY; INDUSTRY; INFECTION; INFLAMMATION; INJURY; ISCHEMIC HEART DISEASE; KIDNEY; KIDNEY FAILURE; LABORATORY TEST; LD 50; LEAF WATER POTENTIAL; LIGHT ABSORPTION; LIVER; LIVER FAILURE; LIVER TOXICITY; MAMMAL CELL; METABOLISM; MORTALITY; MOUTH EDEMA; NERVOUSNESS; NONHUMAN; PANIC; PAPULE; PHOTOALLERGY; PHOTOSENSITIZATION; PHOTOTOXICITY; PLANT LEAF; PREGNANCY; PROTECTION; PROTOPLAST; PRURITUS; RADIATION DERMATITIS; RASH; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SKELETON MALFORMATION; SKIN DEFECT; SKIN DISEASE; SKIN IRRITATION; SKIN TOXICITY; SPERMATOZOON ABNORMALITY; STOMACH MUCOSA LESION; STROKE; SUICIDE ATTEMPT; SURVIVAL; SYNCOPE; THYROID GLAND; TUMOR GROWTH; ULCER; URINARY EXCRETION; VARICOSIS; WOUND HEALING;

ALOE; ANIMALS; CONSENSUS; CONSUMER PRODUCT SAFETY; COSMETICS; HUMANS; PLANT EXTRACTS; PLANT LEAVES; RISK ASSESSMENT; TOXICITY TESTS;

ALOE; ALOE ARBORESCENS; ALOE FEROX; ALOE VERA; ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; MAMMALIA; MUS; RATTUS;

EID: 34447134163     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701351186     Document Type: Review

References (222)

1. Active Organics, Inc. 2002. Material Safety Data Sheet. Actiphyte® of Aloe Vera 10 Fold. www.activeorganics.com
2. Agarwal, O. P. 1985. Prevention of atheromatous disease. Angiology 36:485-492.
3. Agarwala, O. M. 1997. Whole Leaf aloe gel vs. standard Aloe gel. Drugs and Cosmeic Industry Februayy 22-28.
4. Ajabnoor, M. A. 1990. Effects of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol. 28:215-220.
5. Ali, M. I., N. M. Shalaby, M. H. Elgamal, et al. 1999. Antifungal effects of different plant extracts and their major components of selected aloe species. Phytother Res. 13:401-407.
6. Aloecorp. 2001. Time, TEMPERATURE AND Sanitation. www.aloecorp.com
7. Arosio, B., N. Gagliano, L. M. Fusaro, et al. 2000. Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol Toxicol. 87:229-233.
8. Atherton, P. 1998. Aloe vera: Magic or medicine. Nurs Stand. 12:49-54.
9. Avila, H., J. Rivero, F. Herrera, and G. Fraile. 1997. Cytotoxicity of a lowmolecular weight fraction from Aloe vera (Aloe barbadensis Miller) gel. Toxicon. 35:1423-1430.
10. Bader, S., L. Carineli, R. Cozzi, and O. Cozzoli. 1981. Natural hydroxyanthracenic polyglycosides as sunscreens. Cosmet. Toilet. 96:67-74.
11. Badria, F. A. 1994. Is man helpless against cancer? An environmental approach: antimutagenic agents from Egyptian food and medicinal preparations. Cancer Lett. 84:1-5.
12. Blitz, J., J. W. Smith, and J. R. Gerard. 1963. Aloe vera gel in peptic ulcer therapy: Preliminary report. J. Am. Ost. Assoc. 62:731-735.
13. Bobin M. F., M. Raymond, and M. C. Martin. 1994. UVA/UVB absorption properties of natural products. Cosmet. Toilet. 109:63-70.
14. Bouthet, C. F., V. R. Schirf, and W. D. Winters. 1995. Stimulation of neuron like cell growth by aloe substances. Phytother Res. 9:185-188.
15. Brasher, W. J., E. R. Zimmermann, and C. K. Collings. 1969. Effects of prednisolone, indomethacin and Aloe vera gel on tissue culture cells. Oral Surg. Oral Med Oral Pathol. 27:122-128.
16. Briggs, C. 1995. Herbal medicine: Aloe. Can. Pharmaceut. J. 128:48-50.
17. Brown, J. P., and P. S. Dietrich. 1979. Mutagenicity of anthraquinone and benzanthrone derivatives in the Salmonella/microsome test: Activation of anthraquinone glycosides by enzymic extracts of rat cecal bacteria. Mutat. Res. 66:9-24.
18. Brown, J. P., P. S. Dietrich, and R. J. Brown. 1977. Frameshift mutagenicity of certain naturally occurring phenolic compounds in the Salmonella/Microsome test: Activation of anthraquinone and flavonol glycosides by gut bacterial enzymes. Biochem. Soc. Trans. 4:1489-1492.
19. Budavari, S., ed. 1989. The Merck Index. An encyclopedia of chemicals, drugs, and biologicals, 11th ed. Rahway, NJ: Merck & Co.
20. Bunyapraphatsara, N., S. Yongchaiyudha, V. Rungpitarangsi, O. Chokechaijaroenporn. 1996. Anti-diabetic activity of Aloe vera juice. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 3:245-248.
21. Byeon, S. W., R. P. Pelley, S. E. Ullrich, et al. 1998. Aloe barbadensis extracts reduce the production of interleukin-10 after exposure to ultraviolet radiation. J. Invest. Dermatol. 110:811-817.
22. Carrington Labs. 2001. Product specifications for aloe.www. carringtonlabs.com
23. Capasso, F., F. Borrelli, R. Capasso, et al. 1998. Aloe and its therapeutic use. Phytother. Res. 12:S124-127.
24. Capasso, F., N. Mascolo, G. Autore, and M. R. Duraccio. 1983. Effect of Indomethacin on Aloin and 1,8 Dioanthraquinone-induced production of prostaglandin in rat isolated colon. Prostaglandin 26:557-562.
25. Chithra, P., G. B. Sajithlal, and G. Chandrakasan. 1998. Influence of Aloe vera on collagen charactersitics in healing dermal wounds in rats. Mol. Cell. Biochem. 181:71-76.
26. Collin C. E., and C. Collins. 1935. Roentgen dermatitis treated with fresh whole leaf of Aloe vera. Am. J. Roentgen. 33:396-397.
27. 2
28. Corsi, M. M., A. A. Bertelli, G. Gaja, et al. 1998. The therapeutic potential of Aloe vera in tumor bearing rats. Int. J. Tissue React. 20:115-118.
29. 2
30. 2
31. Danhof, I. E., and W. McAnalley. 1983. Stabilized Aloe vera: Effect on human skin cells. Drug and Cosmetic Industry 133, 52, 54, 105-106.
32. Danhof, I. E. 1998. Position statement on polysaccharides. http://www.gothica.com.iasc.poly.html.
33. Davis, R. H., J. J. Di Donato, G. M. Hartman, and R. C. Haas. 1994a. Anti-inflammatory and wound healing of growth substances in Aloe vera. J. Am. Pediatr. Med. Assoc. 84:77-81.
34. Davis, R. H., J. J. DiDonato, R. W. S. Johnson, and C. B. Stewart. 1994b. Aloe vera, hydrocortisone and sterol influence on wound tensile strength and antiinflammation. J. Am. Pediatr. Med. Assoc. 84:614-621.
35. de Witte, P. 1993. Metabolism and pharmacokinetics of anthranoids. Pharmacology. 47(suppl.1):86-97.
36. Dhar, M. L., B. N. Dhar, B. N. Dhawah, et al. 1968. Screening of Indian plants for biological activity Part 1. Ind. J. Exp. Biol. 6:232-247.
37. Diehl, B., and E. E. Teichmuller. 1998. Aloe vera, quality inspection and identification. Agro-Food Industry Hi-tech. 9:14-16.
38. Dixit, V. P., and S. Joshi. 1983. Effect of Aloe barbadensis and clofibrate on serum lipids in Triton-induced hyperlipidaemia in Presbytis monkeys. Ind. J. Med. Res. 78:417-421.
39. Duke, J. A. eds. 1985. Aloe barbadensis Mill. CRC handbook of medicinal herbs, 31-32. Boca Raton, FL: CRC Press.
40. Duke, J. A., and S. M. Beckstrom-Sternberg. 1994. "Acceptable" levels of flavoring ingredients? Dev. Food Sci. 34:741-757.
41. Egger, S. F., G. S. Brown, L. S. Kelsey, et al. 1996. Hematopoietic augmentation by a β-(1,4)-linked mannan. Cancer Immunol. Immunother. 43:195-205.
42. European Union 2000. Opinion concerning the first update of the inventory of ingredients employed in cosmetic products. Section II: Perfume and aromatic raw materials. http://europa.eu.int/comm/food/fs/sc/sccp/out131_en.pdf
43. European Commission. 2002. The rules governing cosmetic products in the European Union. Volume 1.Cosmetic Legislation - Cosmetic products. http://dg3.eudra.org/F3/home.html.
44. Esteban, A., J. M. Zapata, L. Casano, M. Martin, and B. Sabater. 2000. Peroxidase activity in Aloe barbadensis commercial gel: Probable role in skin protection.Planta Med. 66:724-727.
45. Food and Drug Administration (FDA). 1984. Cosmetic product formulation and frequency of use data. FDA Database. Washington, DC: FDA.
46. FDA. 1992. Modification in voluntary filing of cosmetic product ingredient and cosmetic raw composition statements. Final rule. Fed. Register 57:3128-3130.
47. FDA. 1998. The Special Nutritionals/Adverse Event Monitoring System Web Report for aloe. http://www.cfsan.fda.gov.
48. FDA. 2001. Frequency of use of cosmetic ingredients. FDA Database. Washington, DC: FDA.
49. Fogelman, R. W., J. M. Chapdelaine, R. H. Carpenter, and B. H. McAnalley. 1992a. Toxicologic evaluation of injectable acemannan in the mouse, rat and dog. Vet. Hum. Toxicol. 34:201-205.
50. Fogleman, R. W., T. E. Sheelenberger, M. F. Balmer, et al. 1992b. Subchronic Oral administration of acemannan in the rat and dog. Vet. Hum. Toxicol. 34:144-147.
51. Fujita, K., R. Teradaira, and T. Nagatsu. 1976. Bradykinase activity of aloe extract.Biochem. Pharmacol. 25:205.
52. Fujita, K., Y. Yamada, K. Azuma, and S. Hirozawa. 1978. Effect of leaf extracts of Aloe arborescens Mill subsp natalensis Berger on growth of Trichophyton mentagrophytes. Antimicrob. Agents Chemother. 14:132-136.
53. Fulton, J. E. 1990. The stimulation of postdermabrasion wound healing with stabilized Aloe vera gel-polyethylene oxide dressing. J. Dermatol. Surg. Oncol. 16:460-467.
54. Furukawa F., A. Nishikawa, T. Chihara, K. Shimpo, H. Beppu, H. Kuzuya, I. S. Lee, and M. Hirose. 2002. Chemopreventive effects of Aloe arborescens on N-nitrobis( 2-oxypropyl)amine-induced pancreatic carcinogenesis. Cancer Lett. 25:117-122.
55. Garnick, J. J., B. Singh, and G. Winkley. 1998. Effectiveness of a medicament containing silicon dioxide, aloe, and allantoin on aphthous stomatitis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Oral Endod. 86:550-556.
56. Ghannam, N., M. Kingston, I. A. Al-Meshaal, M. Tariq, N. S. Parman, and N. Woodhouse. 1986. The antidiabetic activity of aloes: Preliminary clinical and experimental observations. Horm. Res. 24:288-294.
57. Gjerstad, G. 1969. An appraisal of the Aloe vera juice. Am. Perfum. Cosmet. 84:43-46.
58. Gottschalck, T. E., and G. N. McEwen, Jr., eds. 2004. International cosmetic ingredient dictionary and handbook, 10th ed., Vol. 1, 76-81. Washington, DC: CTFA.
59. Gowda, D. C., B. Neelisiddaiah, and V. Anjaneyalu. 1979. Structural studies of polysaccharides from Aloe vera. Carbohydr. Res.72:201-205.
60. Gramatica, P. D. Monti, G. Speranza, and P. Manitto, 1982. Aloe revisited, the structure of Aloeresin A. Tetrahedron Lett. 23:2423-2424.
61. Green, M. W. 1941. The irritant effect of Aloin. Preliminary note. J. Am. Pharmaceut. Assoc. 30:186-187.
62. Grindlay, D., and T. Reynolds. 1986. The Aloe vera phenomenon:Areviewof the properties and modern uses of the leaf parenchyma gel. J. Ethnopharmacol. 16:117-151.
63. Gutterman, Y., and E. Chauser-Volfson. 2000. The distribution of the phenolic metabolites barbaloin, aloeresin and aloenin as a peripheral defense strategy in the succulent leaf parts of Aloe arborescens. Biochem. Syst. Ecol. 28:825-838.
64. Hamilton, I. 1932. Acute vesicular dermatitis caused by curacao aloes. Med. J.Aust.. 1:302-303.
65. Hammer Pharma. 2000. Hamma Pharma S.p.A. Herbal extracts. Aloe dry extract. http://www.hammerpharma.it/specifications/1/htm.
66. Harris, C., K. Pierce, G. King, et al. 1991. Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms. Mol. Biother. 3:207-213.
67. Hay, J. E., and L. J. Haynes. 1956. The aloins. Part I. The structure of barbaloin. J. Chem. Soc. 3141-3147.
68. Heck, E., M. Head, D. Nowak, et al. 1981. Aloe vera (gel) cream as a topical treatment for outpatient burns. Burns 7:291-294.
69. Hegazy, M. A. A. Mortada, M. R. Hegazy, and M. Helal. 1978. The use of Aloe vera extract in the treatment of experimental corneal ulcers in rabbit. J. Drug Res. Egypt 10:199-209.
70. Heggers, J. P., G. R. Pineless, and M. C. Robson. 1979. Dermaide Aloe/Aloe vera Gel: Comparison of the antimicrobial effects. J. Am. Med. Technol. 41:293.
71. Heidemaan, A., H. G. Miltenburger, and U. Mengs. 1993. The genotoxicity of Senna. Pharmacology 47:179-186, Suppl 1.
72. Heidemaan A., W. Voelkner, and U. Mengs. 1996. Genotoxicity of aloe emodin in vitro and in vivo. Mutat. Res. 367:123-133.
73. Herlihy, J. T., H. A. Bertrand, J. D. Kim, J. Ikeno, and B. P. Yu. 1998. Effects of Aloe vera ingestion in the rat. I. Growth, food and fluid intake and serum chemistry. Phytother. Res. 12:183-188.
74. Hikino, H., M. Takahashi, M. Murakami, C. Konno, et al. 1986. Isolation and hypoglycemic activity of arborans A and B, glycans of Aloe arborescens var Natalensis leaves. Int. J. Crude Drug Res. 24:183-186.
75. Hirata, T., S. Sakano, and T. Suga. 1981. Biotransformation of aloenin, a bitter glucoside constituent of Aloe arborescens, by rats. Experientia 37:1252-1253.
76. Hirata, T., and T. Suga. 1977. Biologically active constituents of leaves and roots of Aloe arborescens var natalensis. Z Naturforsch. 32:731-734.
77. Hogan, D. J. 1988. Widespread dermatitis after topical treatment of chronic leg ulcers and stasis dermatitis. Can. Med. Assoc. J. 138:336-338.
78. Holdsworth, D. K. 1971. Chromones in Aloe species. Planta Med. 19:322-325.
79. Hunter, D., and A. Frumkin. 1991. Adverse reactions to vitamin E and Aloe vera preparations after dermabrasion and chemical peel. Cutis 47:193-196.
80. Hutter, J. A., M. Salman, W. B. Stavinoha, et al. 1996. Anti-inflammatory C-glucosyl chromone from Aloe barbadensis. J. Nat. Prod. 59:541-543.
81. Imanishsi, K., T. Ishiguro, H. Saito, and I. Suzuki. 1981. Pharmacological studies on a plant lectin, Aloctin A. I. Growth and inhibition of mouse methylcholanthrene-induced fibrosarcoma (Meth A) in ascites form by Aloctin A. Experientia 37:1186-1187.
82. 2
83. 2
84. International Aloe Science Council (IASC). 2001a. Polymerase chain reaction: A new method for the identification of aloe. http://www.iasc.org/ orndorf.html.
85. IASC. 2001b. Aloe vera, Quality inspection and identification. www.iasc.org.
86. IASC. 2003. IASC addresses aloe nomenclature for CTFA. Inside Aloe September, 2003. www.iasc.org.
87. Ishii, Y., H. Tanizawa, and Y. Takino. 1984. Fluorophotometry of barbaloin in aloe. Chem. Pharm. Bull. (Tokyo). 32:4946-4950.
88. Ishii, Y., H. Tanizawa, and Y. Takino. 1987. Determination of barbaloin in rat serum. Chem. Pharm. Bull. (Tokyo). 35:4642-4644.
89. Ishii, Y., H. Tanizawa, and Y. Takino. 1990. Studies of Aloe. III. Mechanism of laxative effect. Chem. Pharm. Bull. 38:197-200.
90. Ishii, Y., H. Tanizawa, and Y. Takino. 1994. Studies of Aloe. V. Mechanism of cathartic effect. Biol. Pharm. Bull. 17:651-653.
91. 2
92. 2
93. 2
94. 2
95. Joint Committee of the Pharmaceutical Society and the Society for Analytical Chemistry on Recommended Methods for the Evaluation of Drugs. 1967. The chemical assay of Aloes. Analyst 92:593-596.
96. Karaca, K., J. M. Sharma, and R. Norgen. 1995. Nitric oxide production by chicken macrophages activated by acemannan, a complex carbohydrate extracted from Aloe vera. Int. J. Immunopharmacol. 17:183-188.
97. 2
98. 2
99. Kacew, S. 1993. Neonatal toxicology. Gen. Appl. Toxicol. 2:1047-1068.
100. Kahlon, J. B., M. C. Kemp, R. H. Carpenter, et al. 1991a. Inhibition of AIDS virus replication by acemannan in vitro. Mol. Biother. 3:127-135.
101. Kahlon, J. B., M. C. Kemp, and N. Yawei. 1991b. In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir. Mol. Biother. 3:211-220.
102. Kar, A., S. Panda, and S. Bharti. 2002. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J. Ethnopharmacol. 81:281:285.
103. Kim, H. S., S. Kacew, and B. M. Lee. 1999. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller, Lentinum edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 20:1637-1640.
104. Kim, H. S., and B. M. Lee. 1997. Inhibition of benzo [a] pyrene-DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis 18:771-776.
105. Kim, K. H., J. G. Lee, D. G. Kim, et al. 1998. The development of a new method to detect the adulteration of commercial aloe gel powders. Arch. Pharm. Res. 21:514-520.
106. King, G. K., K. M. Yates, P. G. Greenlee, et al. 1995. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J. Am. Anim. Hosp. Assoc. 31:439-447
107. Klein, A. D., and N. S. Penneys. 1988. Aloe vera. J. Am. Acad. Dermatol. 18:714-20.
108. Koo, M. W. 1994. Aloe vera: Anti-ulcer and anti-diabetic effects. Phytother. Res. 8:461-464.
109. Kuo, P.-L., T.-C. Lin, and C.-C. Lin. 2002. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 16:1879-1892.
110. Kuzuya, H., I. Tamai, H. Beppu, et al. 2001. Determination of aloenin, barbaloin, and isobarbaloin by micellar electrokinetic chromatorgraphy. J. Chromatogr. B Biomed. Sci. Appl. 752:91-97.
111. Lagarto Parra, A., R. Yhebra, G. Sardinas, et al. 2001. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50) in mice to determine oral acute toxicity of plant extracts. Phytomedicine 8:395-400.
112. 14C-aloe-emodin after oral administration to male and female rats. Pharmacology. 47:110-119, suppl 1.
113. Lee, C. K., S. S. Han, Y. K. Mo, et al. 1997. Prevention of ultraviolet radiation-induced suppression of accessory cell function of Langerhans cells by Aloe vera gel components. Immunopharmacology 37:153-162.
114. Lee, C. K., S. S. Han, Y. K. Shin, et al. 1999. Prevention of ultraviolet radiation-induced suppression of contact hypersensitivity by Aloe vera gel components. Int. J. Immunopharmacol. 21:303-310.
115. Lee, H.-Z., 2001. Protein kinase C involvement in aloe-emodin and emodin-induced apoptosis in lung cell carcinoma cell. Br. J. Pharmacol. 5:1093-1103.
116. Lee, H.-Z., S.-L. Hsu, M.-C. Liu, and C.-H. Wu. 2001. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol. 23:287-295.
117. Lee, J. K., M. K. Lee, Y.-P. Yun, et al. 2001. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int. Immunopharmacol. 1:1275-1284
118. Lee, K. Y., J. H. Park, M. H. Chung, et al. 1997. Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of Cyclin E, CDK2 and CDC25A in SK-HEP-1cells. Biochem. Mol. Biol. Int. 41:285-292.
119. Lee, M. J., S. H. Yoon, S. K. Lee, et al. 1995. In vivo angiogenic activity of dichloromethane extracts of Aloe vera gel. Arch. Pharm. Res. 18:332-335.
120. Lissoni, P., L. Giani, S. Zerbini, P. Trabattoni, and F. Rovelli. 1998. Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus Aloe vera in untreatable advanced solid neoplasms. Nat. Immunol. 16:27-33.
121. Lorenzett, L. J., R. Salisbury, J. Beal, and J. Baldwin. 1964. Bacteriostatic property of Aloe vera. J. Pharm. Sci. 53:1287.
122. Loveman, A. B. 1937. Leaf of Aloe vera in treatment of roentgen ray ulcers. Arch. Dermatol. Syphilol. 36:838-843.
123. Mabusela, W. T., A. M. Stephen, and M. C. Botha. 1990. Carbohydrate polymers from Aloe ferox leaves. Phytochemistry 29:3555-3558.
124. Madis, V. H., and M. M. Omar. 1989. Aleoferon isolation, manufacturing and its application. United States Patent 4,861,761.
125. Makino, K., A. Yagi, and I. Nishioka. 1973. Studies on the constituents of Aloe arborescens (Miller): The structure of aloearbonaside, a glucoside of a new type naturally occurring chromene. Chem. Pharm. Bull. 21:149-156.
126. Mandeville, F. B. 1939. Aloe vera in the treatment of radiation ulcers of mucous membranes. Radiology 32:598-599.
127. Marshal, G. D., A. S. Gibbons, and L. S. Parnell. 1993. Human cytokines induced by acemannan (abstract 619). J. Allergy Clin. Immunol. 91:295.
128. Maze, G., R. N. Terpolilli, and M. Lee. 1997. Aloe vera extract prevents aspirin-induced acute gastric mucosal injury in rats. Med. Sci. Res. 25:765-766.
129. McAnalley, B. H. 1990. Processes for preparation of Aloe products, products produced thereby and composition thereof. United States Patent 4,917,890.
130. McCarthy, T. J. 1969. Distribution of glycosyl compounds in South African aloe species. Planta Med. 17:1-7.
131. McCarthy, T. J., and L. J. Haynes. 1967. The distribution of aloesin in some South African aloe species. Planta Med. 15:342-344.
132. McCauley, R., J. P. Haggers, and M. C. Robson. 1990. Frostbite-methods to minimize tissue loss. Postgrad. Med. 88:67-70.
133. 2
134. Meadows, T. P. 1980. Aloe as a humectant in new skin preparations. Cosmet. Toilet. 95:51-56
135. Ministry of Health, Labor and Welfare (MHLW). March 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045. Japan.
136. MHLW. March 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045. Japan.
137. Morimoto, I., F. Wantanabe, and T. Osawa. 1982. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/ microsome reversion assay. Mutat. Res. 97:81-102.
138. Morrow, D. M., M. J. Rapaport, and R. A. Strick. 1980. Hypersensitivity to Aloe. Arch. Dermatol. 116:1064-1065.
139. M̈uller, S. O., I. Eckert, W. K. Lutz, and H. Stopper. 1996. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? Mutat. Res. 371:165-173.
140. Nakamura, T., and S. Kotajima. 1984. Contact dermatitis from Aloe arborescens. Contact Dermatitis 11:51.
141. Nakamura, H., and T. Okuyama. 1990. Gas chromatographic and mass spectral determination of aloenin in skin-care cosmetics. Chromatography 509:377-382.
142. Nakano, M., T. Yamagishi, T. Takahashi, and H. Kaneshima. 1985. Analysis of plant components in cosmetics. Part I. Determination of aloenin, a component of Aloe arborescens Mill in Lotion. Hokkaidoritsu Eisei Kenkyushoh. 35:98-101.
143. Nath, K., N. Sethi, R. K. Singh, and A. K. Jain. 1992. Commonly used Indian abortifacient plants with special reference to their teratologic effects in rats. J. Ethnopharmacol. 36:147-154.
144. Natow, A. J. 1986. Aloe vera, fiction or fact. Cutis 37:106, 108.
145. Norikuri, T., D. O. Kennedy, A. K. Nyarko, A. Kojima, and I. Matsui-Yuasa. 2002. Protective effect of aloe extract against the cytotoxicity of 1,4-napthoquinone in isolated rat hepatocytes involves modulation in cellular thiol levels. Pharmacol. Toxicol. 5: 278-284.
146. Northway, R. B. 1975. Experimental use of Aloe vera in clinical practice. Vet. Med. Small Anim. Clin. 70:89.
147. Norton, S. J., V. Talesa, and W. J. Yuan. 1990. Glyoxalase I and glyoxalase II from Aloe vera: Purification, characterization and comparison with animals Glyoxalases. Biochem. Int. 22:411-418.
148. Olsen, D. L., W. Raub Jr., C. Bradley, et al. 2001. The effect of Aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol. Nurs. Forum. 28:543-547.
149. Parmar, N. S., M. Tariq, M. A. Al-Yahya, et al. 1986. Evaluation of Aloe vera leaf exudates and gel for gastric and duodenal anti-ulcer activity. Fitoterapia 57:380-383.
150. Parry, O., and C. Matambo. 1992. Some pharmacological actions of aloe extracts and Cassia abbreviata on rats and mice. Cent. Afr. J. Med. 38:409-414.
151. Patri, F., and V. Silano. 2002. Plants in Cosmetics, plants and plant preparations used as ingredients for cosmetic product, 79-80. Strasbourg: Council of Europe Publishing.
152. Pecere, T., M. V. Gazzola, C. Mucignat, et al. 2000. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 60:2800-2804.
153. Peny, S. Y., J. Normal, G. Curtin, et al. 1991. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator acemannan. Mol. Biother. 3:79-87.
154. Proserpi, G. 1976. Natural sunscreens: vegetable derivatives as sunscreens and tanning agents. Cosmet. Toilet. 91:34-36.
155. Pugh, N., S. A. Ross, M. A. ElSohly, and D. S. Pasco. 2001. Characterization of aloeride, a new high molecular weight polysaccharide from Aloe vera with potent immunostimulatory activity. J. Agric. Food Chem. 49:1030-1034.
156. Qiu, Z., K. Jones, M. Wylie, et al. 2000. Modified Aloe barbadensis polysaccharide with immunomodulatory Activity. Planta Med. 66:152-156.
157. Ramamoorthy, L., and I. R. Tizard. 1998. Induction of apoptosis in a macrophage cell line RAW264.7 by acemannan, a β (1,4) acetylated mannan. Mol. Pharmacol. 3:415-421.
158. Reynolds, T., and A. C. Dweck. 1999. Aloe vera leaf Gel: A review update. J. Ethnopharmacol. 68:3-37.
159. Roberts, D. B., and E. L. Travis. 1995. Acemannan-containing wounddressing gels reduce radiation-induced skin reactions in C3H mice. Int. J. Radiat. Oncol. Biol. Phys.15:1047-1052.
160. Roboz, E., and A. J. Haagen-Smit. 1948. A mucilage from Aloe vera. J. Am. Chem. Soc. 70:3248-3249.
161. Robson, M. C., J. Heggers, and W. J. Hagstrom. 1982. Myth, magic, witchcraft or fact? Aloe vera revisited. J. Burn Care Rehab. 3:157-162.
162. Ross, S. A., M. A. ElSohly, and S. P. Wilkins. 1997. Quantitative analysis of Aloe vera mucilagenous polysaccharides in commercial Aloe vera products. J. AOAC Int. 80:455-457.
163. Rowe, T. D., and L. M. Parks. 1941. Phytochemical study of Aloe vera leaf. J. Am. Pharm. Assoc. 30:262-266.
164. Sabeh, F., T. Wright, and S. J. Norton. 1993. Isoenzymes of superoxide dismutase from Aloe vera. Enzyme Protein 47:92-98.
165. Sabeh, F., T. Wright, and S. J. Norton. 1996. Purification and characterization of a glutathione peroxidase from Aloe vera plant. Enzyme Protein 49:212-221.
166. Saleem, R., S. Faizi, B. S. Siddiqui, et al. 2001. Hypotensive effects of chemical constituents from Aloe barbadensis. Planta Med. 67:757-760.
167. Saito, H., K. Imanishi, and S. Okabe. 1989. Effects of aloe extracts, aloctin A, on gastric secretion and on experimental gastric lesions in rats. Yakugaku Zasshi 109:335-339.
168. Sauchak, U. I. 1977. Acute bulbous allergic dermatitis due to local application of aloe leaves. Vestn. Dermatol. Venerol. 12:44-45.
169. Shah, A. H., S. Qureshi, M. Tariq, and A. M. Ageel. 1989. Toxicity studies on six plants used in the traditional Arab system of medicine. Phytother. Res. 3:25-29.
170. Shamaan, N. A., K. A. Kadir, A. Rahmat, and W. Z. Ngah. 1998. Vitamin C and Aloe vera supplementation protects from chemical hepatocarcinogenesis in the rat. Nutrition 14:846-852.
171. Sheets, M. A., B. A. Unger, G. F. J. Giggleman, and I. R. Tizard. 1991. Studies on the effect of acemannan on retrovirus. Mol. Biother. 3:41-45.
172. Shelton, R. M. 1991. Aloe vera its chemical and therapeutic properties. Int. J. Dermatol. 30:679-683.
173. Shida, T., A. Yagi, H. Nishimura, and I. Nishioka. 1985. Effect of Aloe vera Extract on peripheral phagocytosis in adult bronchial asthma. Planta Med. 36:273-275.
174. Shimpo, K., T. Chihara, H. Beppu, C. Ida, T. Haneko, T. Nagatsu, and H. Kuzya. 2001. Inhibition of azoxymethane-induced aberrant crypt foci formation in rat colorectum by whole leaf Aloe arborescens Miller var. natalensis Berger. Phytother. Res. 15:705-711.
175. Shimpo, K., C. Ida, T. Chihara, H. Beppu, T. Kaneko, and H. Kuzuya. 2002. Aloe arborescens extract inhibits TPA-induced ear oedema, putrescine increase and tumor promotion in mouse skin. Short communication. Phytother. Res. 16:491-493.
176. 2
177. Shoji, A. 1982. Contact Dermatitis to Aloe arborescens. Contact Dermatitis 8:164-167.
178. Siegers, C. P., J. Siemers, and G. Baretton. 1993. Sennosides and aloin do not promote dimethylhydrazine induced colorectal tumors in mice. Pharmacology 47:205-208, Suppl 1.
179. Singh, R. P., S. Dhanalakshmi, and A. R. Rao. 2000. Chemomodulatory action of Aloe vera on the profiles of enzymes associated with carcinogen metabolism and antioxidant status regulation in Mice. Phytomedicine 7:209-219.
180. Strickland, F. M., A. Darvill, P. Albersheim, et al. 1999. Inhibition of UV-induced immune suppression and interleukin-10 production by plant oligosaccharides and polysaccharides. Photochem. Photobiol. 69:141-147.
181. Strickland, F. M., H. K. Muller, L. C. Stephens, et al. 2000. Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe-emodin. Photochem. Photobiol. 72:407-414.
182. Strickland, F. M., R. P. Pelley, and M. L. Kripke. 1994. Prevention of ultraviolet radiation induced suppression of contact and delayed hypersensitivity by Aloe barbadensis gel extracts. J. Invest. Dermatol. 102:197-204.
183. Sturm, P. G., and S. M. Hayes. 1984. Aloe vera In dentistry. J. Bergen County Dent. Soc. 50:11-14.
184. Suga, T., and T. Hirata. 1983. The efficacy of the Aloe plant chemical constituents and biological activities. Cosmet. Toilet. 98:105-108.
185. Suga, T., T. Hirata, and M. Odan. 1972. Aloenin, a new bitter glucoside from aloe species. Chem. Lett. 547.
186. Suga, T., T. Hirata, and K. Tori. 1974. Structure of aloenin, a bitter glucoside from aloe species. Chem. Lett. 715.
187. Suzuki, I., H. Saito, S. Inoue, S. Migita, and T. Takahashi. 1979. Purification and characterization of two lectins from Aloe arborescens Mill. J. Biochem. (Tokyo) 85:163-171.
188. Sydiskis, R. J., D. G. Owen, J. L. Lohr, et al. 1991. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 35:2463-2466.
189. Syed, T. A., M. Afzal, S. A. Ahmad, et al. 1997. Aloe vera extract 0.5% in a hydrophilic cream versus Aloe vera gel for the management of genital herpes in males. A placebo controlled double blind comparative study. J. Dermatol. Treat. 8:99-102.
190. Syed, T. A., S. A. Shamd, A. H. Holt, et al. 1996. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double blind study. Trop. Med. Int. Health. 1:505-509.
191. Tyler, V. E. 1994. Herbs of choice, 155-157. New York: Pharmaceutical Products Press.
192. Tyler, V. E., L. R. Bradley, and J. E. Robbers, ed. 1988. Pharmacognosy, 9th ed., 62-63. Philadelphia: Lea & Febiger.
193. Tello, C. G., P. Ford, and A. M. Iacopino. 1998. In vitro evaluation of complex carbohydrate denture adhesive formulations. Quintessence Int. 29:585-593.
194. Teradaira, R., M. Shinzato, H. Beppu, and K. Fujita. 1993. Anti-gastric ulcer effect of Aloe arborescens Mill. Var natalensis Berber. Phytother. Res. 7:S34-S36.
195. t'Hart, L. A., P. H. van Enckevort, H. van Dijk, and R. P. Labadie. 1988. Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. J. Ethnopharmacol. 23:61-71.
196. Thomas, D. R., P. S. Goode, K. LaMaster, and T. Tennyson. 1998. Acemannan hydrogel dressing versus saline dressing for pressure ulcers. Adv. Wound Care. 11:273-276.
197. Tizard, A. U., D. Busbee, B. Maxwell, and M. C. Kemp. 1995. Effect of acemannan, a complex carbohydrate, on wound healing in young and aged rats. Wounds 6:201-209.
198. Udupa, S. I., A. L. Udupa, and D. R. Kulkarni. 1994. Anti-inflammatory and wound healing properties of Aloe vera. Fitoterapia 65:141-145.
199. Uehara, N., Y. Iwahori, M. Asamoto, et al. 1996. Decreased levels of 2-amino-3methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with β-carotene, α-tocopherol and rreeze dried Aloe. Jpn. J. Cancer Res. 87:342-348.
200. 2
201. USDA, ARS, National Genetic Resource Program. Germplasm Resources Information Network (GRIN). [Online Database] National Germplasm Resources Laboratory, Beltsville, Maryland. Internet site accessed August, 2003 http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
202. van Wyk, B. E., M. C. B. Oudtshoom, and G. F. Smith. 1995. Geographical variation in the major compounds of Aloe ferox exudate. Planta Med. 61:250-253.
203. Vargas F., G. Fraile, M. Velasquez, et al. 2002. Studies on the photostability and phototoxicity of aloe-emodin, emodin and rhein. Pharmazie 57:399-404.
204. Vath, P., W. G. Wamer, and D. E. Falvey. 2002. Photochemistry and photoxicity of aloe-emodin. Photochem. Photobiol. 75:346-352.
205. Viljoen, A. M., B. V. Van Wyk, and L. E. Newton. 2001. The occurrence and taxonomic distribution of the anthrones aloin, aloinoside and microdotin in aloe. Biochem. Syst. Ecol. 29:53-67.
206. Visuthikosol, V., B. Chowchuen, Y. Sukwanarat, et al. 1995. Effect of Aloe vera gel to healing of burn wound in a clinical and histologic study. J. Med. Assoc. Thai 78:403-409.
207. Vogler, B. K., and E. Ernst. 1999. Aloe vera: a systematic review of its clinical effectivness. Br. J. Gen. Pract. 49:823-828.
208. Waller, G. R., S. Mangiafico, and C. R. Ritchey. 1978. A chemical investigation of Aloe barbadensis miller. Proc. Okla. Acad. Sci. 58:69-76.
209. Wasserman, L., S. Avigad, E. Beery, J. Nordenberg, and E. Fenig. 2002. The effect of aloe emodin on the proliferation of a new Merkel cell carcinoma cell line. Am. J. Dermopathol. 24:17-22.
210. Westendorf, J., H. Marquardt, B. Paginsky, et al. 1990. Genotoxicity of naturally occuring hydroxyahthraquinones. Mutat. Res. 240:1-12.
211. Williams, M. S., M. Burk, C. L. Loprinzi, et al. 1996. Phase III double blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int. J. Radiat. Oncol. Biol. Phys. 36:345-349.
212. Winters, W. D., R. Benavides, and W. J. Clouse. 1981. Effects of aloe extracts on human normal and tumor cells in vitro. Econ. Bot. 35:89-95.
213. Woo, S. W., J. X. Nan, S. H. Lee, E. J. Park, Y. Z. Zhao, and D. H. Sohn. 2002. Aloe emodin supresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Pharmacol. Toxicol. 90:193-198.
214. Wright, C. S. 1936. Leaf of Aloe vera in treatment of roentgen ulcers and telangiectasis. J. Am. Med. Assoc. 103:1363-1364.
215. Yagi, A., T. Egusa, M. Arase, M. Tanabe, and H. Tsugi. 1997. Isolation and characterization of the glycoprotein fraction with a proliferation-promoting activity on human and hamster cells in vitro from Aloe vera gel. Planta Med. 63:18-21.
216. Yagi, A., N. Harada, K. Shimomura, and I. Nishioka. 1987. Bradykinin-degrading glycoprotein in Aloe arborescens var. natalensis. Planta Med. 53:19-21.
217. Yagi, A., K. Machii, H. Nishimura, et al. 1985. Effect of aloe lectin on deoxyribonucleic acid synthesis in baby hamster kidney cells. Experientia 41:669-671.
218. Yagi, A., K. Makino, I. Nishioka, and Y. Kuchino. 1977. Aloe mannan, polysaccharide, from Aloe arborescens var. natalensis. Planta Med. 31:17-20.
219. Yagi, A., J. Nakamori, T. Yamada, et al. 1999. In vivo metabolism of Aloemannan. Planta Med. 65:417-420.
220. Yagi, A., K. Sato, K. Akasaki, and H. Tsuji. 2000. Distribution of verectin in Aloe vera leaves and verectin contents in clonally regenerated plants and the commercial gel powders by immunochemical screening. Planta Med. 66:180-182.
221. Zawahry, M. E., M. R. Hegazy, and M. Helal. 1973. Use of aloe in treating leg ulcers and dermatoses. Int. J. Dermatol. 12:68-73.
222. Zhang, L., and I. R. Tizard. 1996. Activation of a mouse macrophage cell line by acemannan: The major carbohydrate fraction from Aloe vera gel. Immunopharmacology 35:119-128.